A panel of experts discuss the value of clinical pathways in MM disease management. Ryan Haumschild, PharmD, MS, MBA: Let’s talk about clinical pathways. We’ve seen pathways continue to emerge. One ...

A panel of medical experts open a discussion surrounding key treatment strategies in management of hepatocellular carcinoma (HCC). The session commenced with a brief introduction by Haumschild, ...

The free virtual series extends Clinical Pathways Congress with timely insights into evidence-based pathways, value assessment, and access. By extending Clinical Pathways Congress throughout the year, ...

Non–muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC) continue to pose significant clinical and health-economic challenges in ...

Expanding the Multidisciplinary Team in Prediagnostic Care of Lung Cancer: How Else Can We Improve Time to Targeted Treatment in Metastatic Non–Small-Cell Lung Cancer? In the article that accompanies ...

As healthcare becomes more entrenched in the digital revolution, the need for an approved set of protocols for care delivery — clinical pathways — is becoming increasingly critical. Clinical pathways, ...

"What has been missing is the patient's perspective," says one industry consultant. The future of clinical pathways is patient-centric: an approach that balances the long-standing focus on ...

Despite advances in clinical cancer care, cancer survivors frequently report a range of persisting issues, unmet needs, and concerns that limit their ability to participate in life roles and reduce ...

Edward M.R. Macfarlane’s weServed™ platform creates a unified digital ecosystem to bridge gaps between the NHS, charities, ...

Monash University and Seaport Therapeutics have developed a new approach to delivering drug molecules that piggybacks onto ...